(Date:11/20/2008)...WASHINGTON, DC, 19 NOVEMBER 2008 The consumption ...in many countries worldwide and contributes signif... to a new report released today by the Internation...focuses on the use of noncommercial alcohol, defin...umption or limited local trade and counterfeit or ...
(Date:11/20/2008)...archers say finding could be key to new disease-fi...HealthDay News) -- New research on mice suggests i...s to refuel may prove to be key to cancer-fighting...olleagues at Universite catholique de Louvain, in ... sources depending on whether they are in regions ...
(Date:11/20/2008)...INGTON, Nov. 20 The Nat...d the American Medical Association,s recent decisi... called on physician and patient advocates to join...by health-insurance plans. , , "Physicians ...ules," said Gary A. Puckrein, PhD, President and C...
(Date:11/20/2008)..., Nev., Nov. 20 Reno,s Downtown Ba...ganza on Saturday, Nov. 15 as over 850 guests fill...o,s most cherished institutions, Saint Mary,s Regi...ts and many of Nevada,s prominent leaders, includi... , , To view the Multimedia News Release, g...
Breaking Medicine News(10 mins):Health News:Report finds extensive use of illicit alcohol 2Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Photos: Nevada's Saint Mary's Regional Medical Center Raises $1.3 Million During Centennial Soiree 2(Date:11/20/2008)...ical data from a prospective,registry presented t...DVT,treatment with the Trellis(R) Peripheral Infu...ara, CA) successfully breaks up the blood clot in ...technique, called isolated pharmacomechanical thro...fely than current catheter-directed thrombolysis,...
(Date:11/20/2008)...swire/ -- The Scandinavian-based drug,development...studies on its,lead antimicrobial candidate LTX-1...dies showed that the novel lytic peptidomimetic ha...tly better towards killing Staphylococcus,aureus ...dard drugs. In,addition to this it has proven eff...
(Date:11/19/2008)...wire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and Mi...y of,Takeda Pharmaceutical Company Limited (TSE: ...se 3 MONET1 trial evaluating motesanib (AMG 706) i... the first-line treatment of,advanced non-small c...nded,following a planned safety data review of 60...
(Date:11/19/2008)...ngs on critical enzyme,s regulation may hold key t...sorders , , MEMPHIS, Tenn., Nov. 19 /PRNews...en,s Research Hospital have gained new insights in...es called calpains. , , As the cell,s mole...lular processes, including the movement of cells i...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3ValueOptions 28R 29 New Mexico Provides 2410 3 Million for Community Behavioral Health Care Organizations 17390 1ValueOptions 28R 29 New Mexico Provides 2410 3 Million for Community Behavioral Health Care Organizations 17390 2JIC Invests in Three New Alternative Energy Projects 4751 1JIC Invests in Three New Alternative Energy Projects 4751 2JIC Invests in Three New Alternative Energy Projects 4751 3JIC Invests in Three New Alternative Energy Projects 4751 4JIC Invests in Three New Alternative Energy Projects 4751 5American Cancer Society report details cancer prevention efforts 17385 1American Cancer Society report details cancer prevention efforts 17385 2American Cancer Society report details cancer prevention efforts 17385 3American Cancer Society report details cancer prevention efforts 17385 4Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 1Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 2Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 3...WIRE)--Apr 3, 2007 - Arrowhead Research,Corporatio...majority-owned subsidiary Calando Pharmaceuticals,...ive effect of the siRNA sequence,selected as the t...und, CALAA-01., The paper, entitled "Potent siRNA ...2 Reduce Cell Proliferation In vitro and In,vivo",...
...ewly published results in the,International Journa...servational ‘PREDICTIVE™ study’*...ople effectively treats diabetes,without causing w...amining patient outcomes when,Levemir® –...he everyday clinical setting. In the European coho...
Other Medicine Technology:Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3New Data Confirm That Use of Levemir Can Limit Weight Gain 2New Data Confirm That Use of Levemir Can Limit Weight Gain 3New Data Confirm That Use of Levemir Can Limit Weight Gain 4New Data Confirm That Use of Levemir Can Limit Weight Gain 5New Data Confirm That Use of Levemir Can Limit Weight Gain 6... of the most modern lithotripters available today ...om being designed for the treatment of the entire ...LITH SLX can also be employed for a variety of oth...e for the treatment of gallstones or for orthopead...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only.
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: